Literature DB >> 7619082

Hormonal regulation of the zonated expression of cytochrome P-450 3A in rat liver.

T Oinonen1, K O Lindros.   

Abstract

Most cytochrome P-450 enzymes are expressed characteristically in a zonated pattern in the liver. The factors responsible for this heterogenous expression are largely unknown. Here we report how growth hormone and tri-iodothyronine regulate the steroid-hydroxylating cytochrome P-450 (CYP) 3A forms, which are constitutively expressed mainly in the perivenous (downstream) liver region. By comparing cell lysates obtained from the periportal and perivenous acinar regions we observed that the elevated CYP3A expression observed after hypophysectomy was due mainly to a dramatic increase in the normally silent periportal region. This effect was particularly strong in females. Treatment with growth hormone re-established the perivenous expression pattern, a finding corroborated by immunohistochemical analysis of liver sections. Analysis of periportal and perivenous mRNA by reverse-transcriptase PCR demonstrated that in males the changes in CYP3A2 mRNA paralleled the changes at the protein level. In females, CYP3A2 mRNA was detected only after hypophysectomy, and the zonal protein changes seemed to be governed by changes in CYP3A1 mRNA levels. Treatment of hypophysectomized animals with tri-iodothyronine also suppressed the expression of CYP3A, both in males and females. However, this occurred almost exclusively in the periportal region. This was observed both at the protein level, as determined by immunoblotting and immunohistochemically, and at the CYP3A1 and 3A2 mRNA level. These results indicate that growth hormone and thyroid hormone regulate the expression of CYP3A genes zone-specifically by suppressing their transcription in the periportal (upstream) region of the liver.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619082      PMCID: PMC1135799          DOI: 10.1042/bj3090055

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

Review 1.  Metabolic zonation of the liver: regulation and implications for liver function.

Authors:  R Gebhardt
Journal:  Pharmacol Ther       Date:  1992       Impact factor: 12.310

2.  Cytochrome P-450 distribution in rat liver and the effect of sodium phenobarbitone administration.

Authors:  P E Gooding; J Chayen; B Sawyer; T F Slater
Journal:  Chem Biol Interact       Date:  1978-03       Impact factor: 5.192

Review 3.  The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature.

Authors:  D R Nelson; T Kamataki; D J Waxman; F P Guengerich; R W Estabrook; R Feyereisen; F J Gonzalez; M J Coon; I C Gunsalus; O Gotoh
Journal:  DNA Cell Biol       Date:  1993 Jan-Feb       Impact factor: 3.311

4.  An immunohistochemical study on the localization and distributions of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 within the livers of untreated rats.

Authors:  J Baron; J A Redick; F P Guengerich
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

5.  Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation.

Authors:  F J Gonzalez; B J Song; J P Hardwick
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

6.  cDNA cloning and characterization of a novel member of steroid-induced cytochrome P450 3A in rats.

Authors:  S Kirita; T Matsubara
Journal:  Arch Biochem Biophys       Date:  1993-12       Impact factor: 4.013

7.  Growth hormone mediates zone-specific gene expression in liver.

Authors:  T Oinonen; E Nikkola; K O Lindros
Journal:  FEBS Lett       Date:  1993-07-26       Impact factor: 4.124

8.  Complete cDNA and protein sequence of a pregnenolone 16 alpha-carbonitrile-induced cytochrome P-450. A representative of a new gene family.

Authors:  F J Gonzalez; D W Nebert; J P Hardwick; C B Kasper
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

9.  Preparation and characterization of monoclonal antibodies to pregnenolone 16-alpha-carbonitrile inducible rat liver cytochrome P-450.

Authors:  S S Park; D J Waxman; H Miller; R Robinson; C Attisano; F P Guengerich; H V Gelboin
Journal:  Biochem Pharmacol       Date:  1986-09-01       Impact factor: 5.858

10.  Heterogeneous distribution of glutamine synthetase among rat liver parenchymal cells in situ and in primary culture.

Authors:  R Gebhardt; D Mecke
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  5 in total

1.  Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients.

Authors:  Nuntiya Somparn; Upa Kukongviriyapan; Wichittra Tassaneeyakul; Arunee Jetsrisuparb; Veerapol Kukongviriyapan
Journal:  Eur J Clin Pharmacol       Date:  2006-11-21       Impact factor: 2.953

2.  Effect of testosterone suppression on the pharmacokinetics of a potent gnRH receptor antagonist.

Authors:  Eugenia A Iatsimirskaia; Margaret L Gregory; Kenna L Anderes; Rosemary Castillo; K Eric Milgram; David R Luthin; Ved P Pathak; Lance C Christie; Haresh Vazir; Mark B Anderson; John M May
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

Review 3.  Zonation of hepatic cytochrome P-450 expression and regulation.

Authors:  T Oinonen; K O Lindros
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

4.  Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism.

Authors:  Antonius E van Herwaarden; Els Wagenaar; Cornelia M M van der Kruijssen; Robert A B van Waterschoot; Johan W Smit; Ji-Ying Song; Martin A van der Valk; Olaf van Tellingen; José W A van der Hoorn; Hilde Rosing; Jos H Beijnen; Alfred H Schinkel
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

5.  A high-fat high-energy diet influences hepatic CYP3A expression and activity in low-birth-weight developing female rats.

Authors:  Shao-Qing Ni; Yin Lou; Xiu-Min Wang; Zheng Shen; Jue Wang; Zheng-Yan Zhao; Su Zeng
Journal:  World J Pediatr       Date:  2016-06-30       Impact factor: 2.764

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.